Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A person must give their voluntary written agreement to participate before any screening takes place (or a legally authorised representative may do so on their behalf).
- People who are at least 18 years old at the time of signing the consent form.
- People who are able to read, understand, and speak Dutch.
- People who have been scheduled for a specific type of rectal cancer surgery (called Total Mesorectal Excision or Partial Mesorectal Excision) or who are on a 'Watch and Wait' programme for rectal cancer.
Who may not be able to join:
- People who have had a different type of bowel surgery, such as a Hartmann procedure, abdominoperineal excision, transanal endoscopic microsurgery, or sigmoid resection.
- People who had problems controlling their bowel movements (fecal incontinence) before their surgery.
- People who have a neurological condition (a disorder affecting the brain, nerves, or spinal cord) that affects how their bowel works.
- People who have previously had radiation therapy to the pelvic area or bowel surgery for reasons unrelated to cancer.
- People who already have a permanent stoma (a surgically created opening on the abdomen for waste to leave the body).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Inge Geraerts, PhD, KU Leuven
Phone: +3216329120
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Bowel symptoms after rectal cancer treatment; The evaluation of Quality of Life (QoL) related to bowel symptoms after rectal cancer treatment; The evaluation of overall Quality of Life (QoL) after rectal cancer treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.